<p>
  Expression data from multiple hormone treatments for Gransden WT protonema on several media.
</p>
<h4>Experimental Conditions (3 replicates unless otherwise noted):</h4>

<ul>
  <li><span style="color:black;">control - BSL</span> [2 replicates]</li>
  <li><span style="color:black;">ABA - BSL</span></li>
  <li><span style="color:black;">control - BSLA</span></li>
  <li><span style="color:black;">OPDA - BSLA</span></li>
  <li><span style="color:black;">Acetone - BSL</span></li>
  <li><span style="color:black;">Strigolactone - BSL</span></li>
  <li><span style="color:black;">Continuous Light - BSL</span></li>
  <li><span style="color:black;">Continuous light GA9 - BSL</span></li>
</ul>


<p>
  <!-- Phosphate deficiency time series were published in <a href="https://onlinelibrary.wiley.com/doi/10.1111/tpj.14607">Fernandez-Pozo et al., 2020</a>.  -->
  These data were published in <a href="https://onlinelibrary.wiley.com/doi/abs/10.1111/tpj.13940">Perroud et al., 2018</a>.
</p>

<table>
  <tr style="border-bottom: solid 1px">
    <th>
      <b>Abbreviations</b>
    </th>
    <th>
    </th>
  </tr>
  <tr><td>BCD solid</td><td>BSL</td></tr>
  <tr><td>BCDA (ammonium) solid</td><td>BSLA</td></tr>
  <tr><td>Gibberellin A9 methyl-ester</td><td>GA9</td></tr>
  <tr style="border-bottom: solid 1px; padding-bottom:20px;height:45px">
    <td>12-oxophytodienoic acid</td>
    <td>OPDA</td>
  </tr>
</table>

<p>
Note: OPDA is a precursor of jasmonic acid.
</p>



